Site Map About AGI    + Company    + KME Approach Who we are   Management    + John Devane PhD, Chief Executive Officer    + Mary Martin PhD, Chief Operating Officer    + David Young, Ph.D, President, US Operations    + David Kelly, Chief Financial Officer    + Patrick Ashe, Vice President, Business Development    + Jackie Butler PhD, Vice President, Biopharmaceutics    + Paul Stark, Vice President, Pharmaceutical Development    + John Kelly PhD, Chief Scientific Advise   Board of Directors   + Ronan Lambe PhD, Non-Executive Chairman   + John Devane Ph.D, Chief Executive Officer   + Mary Martin Ph.D, Chief Operating Officer   + David Young, Ph.D, President, US Operations   + David Kelly, Chief Financial Officer   + Patrick Ashe, Senior Vice President, Business Development   + Chris Blackwell PhD, Non-Executive Director   + Frank Kenny, Non-Executive Director   + Peter Sandys, Non-Executive Director   + John O’ Sullivan, Non-Executive Director  Investors   + Corporate Presentation   + Corporate Reports   + Share Price  Products    + AGI - 001 | AGI - 003 | AGI - 004 | AGI - 006 | AGI - 010 | AGI - 022  Press Releases  Contact Us